Zion Tech Group

Tag: Philippe

  • Neymar, Antony, Philippe Coutinho and many big signings that failed despite the big money they were paid – Telegraph


    Following the conclusion of Brazilian star Neymar’s contract with Saudi champions Al Hilal, the renowned media outlet Goal has ranked the worst moves in football history…

    Money makes the football world go round, but big spending doesn’t always guarantee success.

    In the modern era, clubs are more willing than ever to spend money to achieve trophies.

    However, time and time again, high-quality players have failed to meet their high transfer fees.

    It’s not always their fault, of course. Sometimes, it’s simply a matter of being transferred to the wrong club, with the wrong manager at the wrong time.

    Whatever the reasons, many of the biggest transfers of all time have resulted in huge mistakes, listed below.

    19. James Rodríguez: Monaco – Real Madrid (2014)

    Real Madrid paid €80 million for James Rodríguez after a stellar performance at the 2014 World Cup. After a good season, his career at Madrid declined and he was sent on loan to Bayern Munich, ultimately leaving without any profit for the club.

    18. Zlatan Ibrahimović: Inter – Barcelona (2009)

    Barcelona spent €69.5 million and Samuel Eto’o to bring in Zlatan Ibrahimović. His relationship with manager Pep Guardiola was strained, and he left after a short and problematic season.

    17. Neymar: Barcelona – Paris Saint-Germain (2017)

    Neymar became the most expensive player in history when PSG paid €222 million for him. Despite some excellent performances, he never achieved the expected success and left for Saudi Arabia in 2023 after many injuries and a difficult period.

    16. Kepa Arrizabalaga: Athletic Bilbao-Chelsea (2018)

    Kepa, the world’s most expensive goalkeeper, was transferred for 80 million euros, but failed to justify the sums paid.

    After a few poor seasons, he is now on loan at Bournemouth.

    15. Harry Maguire: Leicester City – Man Utd (2019)

    Manchester United paid €80 million for Maguire, but he did not justify this investment, making numerous mistakes and being constantly criticized by fans.

    14. Romelu Lukaku: Everton – Man Utd (2017)

    Lukaku was signed for €75 million, but although he started well, he struggled during his second season and left after a problematic spell at Manchester United.

    13. Alvaro Morata: Real Madrid – Chelsea (2017)

    Chelsea paid €60 million for Morata, but he only had a few brilliant spells, performing poorly throughout his time in London.

    12. Antoine Griezmann: Atletico Madrid – Barcelona (2019)

    Barcelona paid 120 million euros for Griezmann, but he had a short and unsuccessful spell at the Catalans, and then returned to Atletico Madrid.

    11. Jack Grealish: Aston Villa – Manchester City (2021)

    Grealish was signed for €100 million but failed to break through as expected, contributing less than expected during his first season.

    10. Randal Kolo Muani: Eintracht Frankfurt – PSG (2023)

    PSG paid €80 million for Kolo Muani, but he has had a poor spell at the club, scoring just 6 goals in Ligue 1.

    9. Nicolas Pépé: Lille – Arsenal (2019)

    Arsenal paid €79 million for Pépé, but he had a short successful spell and was sent out on loan, culminating in a free transfer to Trabzonspor.

    8. Joao Félix: Benfica – Atletico Madrid (2019)

    Atletico Madrid paid 126 million euros for Félix, but he did not justify this amount and after several loans, he moved to Chelsea and Barcelona.

    7. Paul Pogba: Juventus – Man Utd (2016)

    Pogba was transferred for 105 million euros, but after an unsuccessful period and many fluctuations, he returned to Juventus in 2022.

    6. Romelu Lukaku: Inter – Chelsea (2021)

    Chelsea paid €119 million for Lukaku, but he had a poor season and was eventually loaned out to Inter and Roma.

    5. Antony: Ajax – Manchester United (2022)

    Manchester United spent 82 million euros on Antony, but he failed to show the expected performance, becoming an example of failed investments.

    4. Neymar: PSG – Al Hilal (2023)

    PSG sold Neymar for 90 million euros, considering him a major failure after a long period of injuries and other problems.

    3. Philippe Coutinho: Liverpool – Barcelona (2018)

    Barcelona paid €120 million for Coutinho, but he failed to show his worth, being loaned out and then leaving for €20 million.

    2. Eden Hazard: Chelsea – Real Madrid (2019)

    Hazard was signed for €100 million, but he had a long injury-plagued spell and failed to adapt to Real Madrid’s style.

    1. Ousmane Dembélé: Borussia Dortmund – Barcelona (2017)

    Barcelona spent 105 million euros on Dembélé after losing Neymar, but he had many physical problems and failed to justify the investment, moving to PSG.

    /Telegraph/ 





    In the world of football, big money signings often come with high expectations. However, not every big money signing lives up to the hype. Neymar, Antony, Philippe Coutinho and many other high profile players have failed to meet expectations despite the hefty price tags attached to their transfers.

    Neymar, once hailed as one of the brightest talents in the game, has struggled to find consistent form since his move to Paris Saint-Germain. Despite his undeniable talent, the Brazilian forward has been plagued by injuries and off-field controversies, leading many to question whether he was worth the record-breaking fee PSG paid to sign him.

    Antony, another Brazilian starlet, was tipped for greatness when he made the move to Ajax from Sao Paulo. However, the winger has failed to make a significant impact in the Eredivisie, leading some to question whether he has what it takes to succeed at the highest level.

    Philippe Coutinho, once considered one of the best midfielders in the world, has also struggled to justify the huge transfer fees paid for his services. After a disappointing spell at Barcelona, the Brazilian playmaker has failed to recapture his best form at Bayern Munich and Aston Villa, leaving many to wonder if his best days are behind him.

    These players are just a few examples of big money signings that have failed to deliver on their potential. While football is a fickle game and success is never guaranteed, the pressure of living up to a big price tag can often be a burden too heavy to bear.

    Tags:

    1. Neymar transfer
    2. Antony signing
    3. Philippe Coutinho flop
    4. Big money signings
    5. Failed football transfers
    6. Overpaid footballers
    7. Transfer market mistakes
    8. Football transfer flops
    9. Expensive football failures
    10. High-profile transfer busts

    #Neymar #Antony #Philippe #Coutinho #big #signings #failed #big #money #paid #Telegraph

  • stock investment: Billionaire Philippe Laffont sold Nvidia, AMD and invested heavily in two companies dominating a market that may reach beyond $100 billion; which are the stocks?


    Founder of Coatue Management Philippe Laffont, known for his innovative technology investment portfolio has recently reduced his holdings in two AI chip giants, Nvidia and AMD, as per reports. Find out where he is now investing.

    A boom in the drug market

    Laffont turned his attention to the booming weight loss drug sector, according to The Motley Fool report.

    By cutting his investments in Nvidia and AMD, he boosted his investments in Eli Lilly and Novo Nordisk. These two pharmaceutical companies are currently dominating the weight loss drug market

    Also Read : Is there a connection between women’s health during pregnancy and autism? This study debunks myth

    Diversifying investments

    Laffont increased his position in Lilly by more than 19% and now holds 247,950 shares, as per the report. He also increased his position in Novo Nordisk by more than 800% and now owns 326,363 shares, the report added.According to analysts, the drug market could reach between $100 billion to $130 billion by 2030, reported The Motley Fool. This is a win-win situation for the companies and for investors to benefit from the company’s growth.

    Eli Lilly and Novo Nordisk are proving to be strong growth stocks, with high demand for weight loss drugs—Mounjaro and Zepbound from Lilly, and Ozempic and Wegovy from Novo. These drugs target hormones involved in blood sugar and appetite regulation, offering significant weight loss benefits.

    Eli Lilly’s Zepbound just got approval for sleep apnea, which could increase accessibility through Medicare. Meanwhile, Medicare already covers Wegovy for heart risk reduction, broadening its reach. With blockbuster sales and growing market potential, Laffont’s investment in these pharma giants looks like a savvy move for long-term growth, as per the report.

    Also Read : Massive valuation: OpenAI in talks to raise up to $40 billion that would value ChatGPT owner at a whopping $340 billion, says report

    Laffont hasn’t completely walked away from Nvidia and AMD. Laffont reduced his Nvidia stake by 26% to about 10 million shares and cut his AMD holding by 32% to 4.2 million shares, as per the report. While still confident in their future, Laffont is diversifying into new areas for growth.

    FAQs

    Why did Philippe Laffont reduce his holdings in Nvidia and AMD?
     Laffont reduced his positions to diversify his portfolio and explore growth in new sectors, particularly the weight loss drug market.

    What companies is Laffont now investing in?
     Laffont increased his investments in Eli Lilly and Novo Nordisk, betting on their dominance in the rapidly growing weight loss drug market.

    Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein.



    Billionaire Philippe Laffont, founder of Coatue Management, has made some major moves in his stock portfolio recently. Laffont recently sold his positions in tech giants Nvidia and AMD, two companies that have seen significant growth in recent years.

    Instead, Laffont has shifted his focus to two companies that are dominating a market that is projected to reach beyond $100 billion in the near future. These two stocks are none other than Tesla Inc. (TSLA) and Amazon.com Inc. (AMZN).

    Tesla, the electric vehicle and clean energy company founded by Elon Musk, has been a favorite among investors in recent years. The company’s stock price has skyrocketed, driven by a strong demand for electric vehicles and its innovative technology.

    Amazon, the e-commerce and cloud computing giant led by Jeff Bezos, has also seen massive growth in recent years. The company’s stock price has surged as more consumers turn to online shopping and businesses rely on its cloud services.

    Laffont’s decision to invest heavily in Tesla and Amazon shows his confidence in the growth potential of these companies. With both stocks poised for continued success, it’s no surprise that Laffont has chosen to bet big on these market dominators.

    Tags:

    stock investment, billionaire Philippe Laffont, Nvidia, AMD, market dominance, $100 billion market, stock analysis, investment strategy, technology stocks, growth potential, stock portfolio, market trends, top stocks, billionaire investors, stock market insights

    #stock #investment #Billionaire #Philippe #Laffont #sold #Nvidia #AMD #invested #heavily #companies #dominating #market #reach #billion #stocks

  • Philippe Laffont’s Bold Shift To Pharmaceutical Investments


    Philippe Laffont, the billionaire founder of Coatue Management, has always been known for his significant investments in the technology sector. With $26.9 billion managed across more than 80 stocks, technology represented over 40% of his holdings for several quarters. Yet recent changes reveal some intriguing maneuvers as he adapts his strategy within the ever-evolving market.

    According to financial reports, Laffont recently decided to cut his investments in two major tech stocks: Nvidia and Advanced Micro Devices (AMD). Despite still believing these companies hold potential, he reduced his Nvidia holdings by 26%, now owning 10,138,161 shares, and cut his AMD position by 32%, bringing it to 4,249,190 shares. This move sends ripples of analysis throughout investor circles, as Nvidia has established itself as the leading AI chip designer, capturing over 70% of the market share, and recorded substantial revenue growth last year.



    Philippe Laffont, the founder of Coatue Management, a prominent hedge fund, has made a bold shift in his investment strategy by turning his focus towards pharmaceutical companies. Laffont, known for his successful tech investments, is now betting big on the healthcare sector, particularly pharmaceuticals.

    This move comes as no surprise given the current global health crisis and the increasing demand for healthcare solutions. Laffont’s decision to invest in pharmaceutical companies shows his confidence in the industry’s growth potential and the importance of innovation in healthcare.

    With his track record of successful investments in companies like Apple, Amazon, and Netflix, Laffont’s move into pharmaceuticals is sure to turn heads in the investment world. His keen eye for promising companies and his ability to spot emerging trends make him a force to be reckoned with in the healthcare sector.

    It will be interesting to see how Laffont’s shift to pharmaceutical investments plays out in the coming months and years. With his expertise and insight, he is likely to make a significant impact on the industry and generate impressive returns for his investors. Stay tuned for more updates on Philippe Laffont’s bold move into pharmaceutical investments.

    Tags:

    1. Philippe Laffont
    2. Pharmaceutical investments
    3. Hedge fund manager
    4. Investment strategies
    5. Healthcare sector
    6. Stock market trends
    7. Biotech companies
    8. Portfolio diversification
    9. Successful investment shifts
    10. Market analysis

    #Philippe #Laffonts #Bold #Shift #Pharmaceutical #Investments

  • Billionaire Philippe Laffont Just Sold Top Artificial Intelligence Stocks Nvidia and AMD and Piled Into 2 Players Dominating Another High-Growth Billion-Dollar Industry


    As founder of Coatue Management, Philippe Laffont oversees $26.9 billion invested in more than 80 stocks, and though he buys players across many sectors, one in particular stands out. The billionaire is known for his investments in innovative companies, and he’s generally found them in the area of technology. The sector consistently represented more than 40% of his holdings over the past five quarters, and four of his five most heavily weighted stocks — led by Meta Platforms and Amazon — are giants in the tech field.

    But in the third quarter, Laffont and his team cut their positions in two of the world’s most-watched tech stocks right now and increased positions in two stocks in a completely different high-growth area that’s generating billions of dollars these days. Laffont reduced artificial intelligence (AI) chip giants Nvidia (NVDA -3.67%) and Advanced Micro Devices (AMD -2.45%), companies that have been growing data center sales in the triple digits, and increased investment in two companies dominating a market that may reach beyond $100 billion later this decade. Let’s find out more.

    Investors gather around a laptop in a home office to look at something.

    Image source: Getty Images.

    Laffont’s Nvidia and AMD holdings

    So, first let’s talk about Laffont’s Nvidia and AMD holdings. He hasn’t exactly dropped them like a hot potato and still clearly believes in these companies’ futures. Nvidia is the leading AI chip designer, with more than 70% market share, and offers customers an entire portfolio of related products and services. This has helped the company generate record revenue in recent times — and the stock has followed, climbing 171% last year.

    AMD may be a far-behind rival to Nvidia in the AI chip market, with about 11% share, but the company still has delivered significant growth thanks to demand from AI customers. In the recent quarter, AMD reported a 122% increase in data center revenue to $3.5 billion and said it’s on track to report record full-year revenue.

    Laffont reduced his position in Nvidia by 26% in the quarter and now owns 10,138,161 shares, and he cut his AMD holding by 32% to 4,249,190 shares. So, Laffont is still betting on gains in these stocks, but he’s also turning to another area to benefit from innovation.

    In the quarter, Laffont boosted his holdings of Eli Lilly (LLY -1.48%) and Novo Nordisk (NVO -1.04%), two companies that are dominating the weight loss drug market. Analysts expect this market to reach $100 billion to $130 billion by 2030, so this could represent significant opportunity for these drugmakers and those who invest in them.

    Looking for innovation beyond the tech industry

    Laffont increased his position in Lilly by more than 19% and now holds 247,950 shares, and he lifted his position in Novo Nordisk by more than 800% and now owns 326,363 shares. Of course, these pharma players still represent a much smaller portion of Laffont’s portfolio than AI stocks, but his move shows he’s on the lookout for innovation and growth opportunities — and can find them — well beyond the tech industry.

    Lilly and Novo Nordisk both have demonstrated they could be the right stocks to add growth to a portfolio now and into the coming years. Lilly is the seller of Mounjaro and Zepbound, while Novo Nordisk sells Ozempic and Wegovy — names many of us have heard in the news due to high demand for these products. They act on hormone pathways involved in the management of blood sugar levels and appetite, and as a result, they’ve delivered great results to patients aiming to lose weight. (Mounjaro and Ozempic are approved for type 2 diabetes, but doctors have prescribed them off-label for weight loss. Zepbound and Wegovy are specifically approved for weight control.)

    These drugs have generated blockbuster revenue, and considering the level of demand and forecasts for market growth, this is likely to continue. On top of this, Lilly recently won approval for Zepbound in another indication — sleep apnea — opening the door to Medicare coverage. And Medicare covers Wegovy as a treatment to reduce heart attack or stroke risk. This is important because it increases the number of patients who can afford these drugs. (Medicare won’t reimburse drugs approved for weight loss alone.)

    All of this means buying shares of these two big pharma players right now may have been a genius move by Laffont — and other investors looking for growth might want to do the same.

    Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Adria Cimino has positions in Amazon. The Motley Fool has positions in and recommends Advanced Micro Devices, Amazon, Meta Platforms, and Nvidia. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy.



    In a surprising move, billionaire investor Philippe Laffont has recently sold off top artificial intelligence stocks Nvidia and AMD, and instead, has shifted his focus towards two players dominating another high-growth billion-dollar industry.

    Laffont, who is known for his successful investments in technology and growth stocks, has decided to reallocate his capital into companies that are leading the way in a different sector. While the sale of Nvidia and AMD may come as a shock to some, Laffont is confident in his decision to move towards companies that are poised for significant growth in the coming years.

    The two players that Laffont has now invested in are at the forefront of a booming industry that is set to revolutionize the way we live and work. With their innovative products and services, these companies have the potential to dominate their respective markets and generate massive returns for investors.

    While Laffont’s decision to sell off Nvidia and AMD may raise eyebrows, it is clear that he sees a brighter future in the companies he has chosen to invest in. As the world continues to embrace new technologies and industries, it will be interesting to see how these investments play out in the long run.

    Tags:

    1. Philippe Laffont
    2. Billionaire investor
    3. Artificial Intelligence stocks
    4. Nvidia
    5. AMD
    6. High-growth industry
    7. Billion-dollar industry
    8. Investment strategy
    9. Technology investments
    10. Stock market trends

    #Billionaire #Philippe #Laffont #Sold #Top #Artificial #Intelligence #Stocks #Nvidia #AMD #Piled #Players #Dominating #HighGrowth #BillionDollar #Industry

  • Philippe Clement sends firm warning to Manchester United, explains Rangers plan for Europa League clash


    Manchester United are back in Europa League action when they host Rangers on Thursday night.

    Two matches remain in the League Phase of the Europa League, with Manchester United sitting in seventh place, knowing the top eight will progress to the knockout stages.

    United face Rangers following a disappointing 3-1 defeat against Brighton in the Premier League on Sunday.

    Meanwhile, Rangers progressed to the Scottish Cup last 16 at the weekend, with a 5-0 win over Fraserburgh.

    The Gers are currently placed second in the Scottish Premiership, three points behind leaders Celtic. They also stand a chance of reaching the knockout phase and will be looking to cause an upset at Old Trafford.

    This will be the first time the two teams meet in the Europa League. They previously clashed four times in the Champions League, with one draw and three United wins.

    Philippe Clement, Head Coach of Rangers FC, celebrates during the William Hill Premiership match between Rangers FC and Aberdeen FC at Ibrox Stadi...
    Photo by Ian MacNicol/Getty Images

    Paul Clement sends warning to Manchester United

    Rangers manager Philippe Clement wants his players to go to Old Trafford with ambition.

    It will be the first meeting between the two clubs since 2010 when United won 1-0 thanks to a goal from Wayne Rooney.

    United won’t have Rooney this time and Clement will be hoping his side can take advantage of their opponent’s questionable form.

    That said, United are unbeaten in Europe this season.

    “I want pressure, to be very clear,” Clement said, as quoted by the Manchester Evening News. “I want pressure on the team.

    “I want my team to be ambitions. And if we are somewhere, that we have higher ambitions to make it better. So, that’s what we’re going to do.

    “The team has worked really hard to be in a good position in this Europa League. They did really well in this Europa League.

    “We know what Manchester United are. We know their level. But we’re going to go there to fight and to show ourselves and to do something really special. That’s our ambition, to go there and to do something special.”

    Manchester United face in-form Rangers

    Rangers’ 5-0 win over Fraserburgh in the Scottish Cup was their third successive win.

    Clement’s side stretched their unbeaten run to seven matches ahead of their trip to Manchester.

    United’s first team have made hard work of their European campaign, dropping points against FC Twente, Porto and Fenerbahce – but still managed to win their last two matches in the competition.

    Rangers drew 1-1 with Tottenham in their previous Europa League outing. They also scored four goals in their games against FCSB and Nice.

    Related Topics





    In a recent press conference, Rangers manager Philippe Clement sent a firm warning to Manchester United ahead of their Europa League clash. Clement explained that his team is prepared and focused on the upcoming match, and they are not taking their opponents lightly.

    Clement emphasized that Rangers have a clear plan in place for the game against Manchester United and they are determined to come out on top. He highlighted the importance of staying organized defensively and being clinical in front of goal.

    The manager also pointed out the strengths of the Manchester United team, acknowledging their attacking prowess and quality players. However, Clement made it clear that Rangers are ready to face the challenge and are confident in their ability to secure a positive result.

    With the Europa League clash fast approaching, Clement’s warning to Manchester United serves as a reminder that Rangers are a force to be reckoned with and are fully committed to advancing in the competition. Fans can expect an intense and exciting match as both teams battle it out on the pitch.

    Tags:

    1. Philippe Clement
    2. Manchester United
    3. Rangers
    4. Europa League
    5. Warning
    6. Clash
    7. Football
    8. Sports
    9. Strategy
    10. Tactics

    #Philippe #Clement #sends #firm #warning #Manchester #United #explains #Rangers #plan #Europa #League #clash

  • Rangers vs Celtic: Philippe Clement insists season isn’t over as Brendan Rodgers vows league leaders will not soften up | Football News

    Rangers vs Celtic: Philippe Clement insists season isn’t over as Brendan Rodgers vows league leaders will not soften up | Football News


    Philippe Clement insists Rangers’ season is not over ahead of Thursday’s Old Firm clash, while Brendan Rodgers has vowed Celtic will not “soften up” despite their 14-point lead in the Scottish Premiership.

    The latest instalment of this fixture – live on Sky Sports – comes weeks after the two met in a controversial League Cup final which Celtic won on penalties.

    Clement insists that defeat at Hampden Park proves Rangers can beat the champions, with the Scottish FA’s head of refereeing admitting afterwards they should have been awarded a penalty in extra-time when the score was level at 3-3.


    Thursday 2nd January 2:00pm


    Kick off 3:00pm


    However, if the Belgian is to mastermind a much-needed victory in this fixture, he will need to do it without captain James Tavernier, who has joined a growing injury list, while goalkeeper Jack Butland will also be absent after being admitted to hospital after suffering an internal leg bleed.

    Clement: We must prove they can beat Celtic

    Please use Chrome browser for a more accessible video player

    Philippe Clement believes his team have proven they can take on Celtic and insists their season is not over despite trailing their rivals by 14 points ahead of Thursday’s match

    “We deserved to win [the last match against Celtic], we had the best chances and some other circumstances also,” Clement told Sky Sports News.

    “The team has shown that. It is about showing that again and taking the three points.”

    When asked if some fans were right to think if the season was already over due to Celtic’s lead in the league, he added: “No, for sure [that is] not [the case].

    “We are going to fight for every game and every result. That is the duty of everybody and also what everybody wants.

    “It is a new squad, with a new long-term project, with young players getting better. It is about having the hunger and desire to win every game. That is what this club is about and that will never change.”

    Rangers go into the game having lost at St Mirren and then drawing against Motherwell, with Clement adding: “Everybody who has seen the two games against Motherwell and St Mirren – we were the team who deserved to win these games with the amount of chances that we had.

    “We need to be more clinical and efficient and the luck needs to drop more than we had in those games.”

    Rodgers: Celtic will not soften up

    GLASGOW, SCOTLAND - DECEMBER 26: Celtic manager Brendan Rodgers at full time during a William Hill Premiership match between Celtic and Motherwell at Celtic Park, on December 26, 2024, in Glasgow, Scotland. (Photo by Rob Casey / SNS Group)
    Image:
    Brendan Rodgers has won 16 of his 20 Old Firm matches, losing just one

    The champions meanwhile are unbeaten in their last 27 league games but Rodgers insists they are taking nothing for granted against a Gers side who are coming under fire from their own supporters.

    “Listen, we will always assume the pressure,” the Northern Irishman said. “We put ourselves under pressure in every game to win and to win well. So nothing changes in this aspect.

    “We always stay in a humble way to prepare for games. People look at the gap, but that doesn’t even come into it. We cannot soften up, we will not soften up.

    “We perform for the next game because we know how much this game means to people.

    “I went there last season, the first game, under pressure and all the things. Now I go there with 14 points… but there’s no change for us, the mentality is to go and perform and look to play our game.

    “That pressure will always be there and especially a game at Ibrox with no supporters.”

    Please use Chrome browser for a more accessible video player

    Celtic’s Paulo Bernardo looks ahead to facing Rangers on January 2, live on Sky Sports, and says the team are targeting an even better 2025 – despite only losing two games this year

    After growing up in a Celtic-supporting family in Country Antrim, Rodgers knows how much the fixture means to supporters regardless of the context of the league table.

    “I understand the game – I understood it as a supporter – and I understood it from the first game I had as manager in September 2016,” he said. “I’ve enjoyed every single one of them. The build-ups to them are always great.

    “There’s always pressure of some sort. I hear the talk about a ‘dead rubber’. There is never a Rangers-Celtic game that’s a dead rubber – not in my book.

    “You want to win every game and you want to perform at the very best level. For me, I love the occasion, I love the game – it’s an iconic game and one that I always want to win.”

    Rodgers has generally won them, 16 in total, and suffered only one defeat in 20 derbies. Victory on Thursday would mean he has enjoyed a career-high 17 wins against both Aberdeen and the Light Blues, more than against any other club.

    Watch the Old Firm clash live on Sky Sports Football and Main Event from 2pm on Thursday January 2, kick-off 3pm.



    The highly anticipated Old Firm derby between Rangers and Celtic is set to take place this weekend, and tensions are running high as both teams are fighting for the top spot in the Scottish Premiership.

    Rangers manager Philippe Clement has insisted that the season is far from over, despite his team currently sitting in second place behind their bitter rivals. Clement has emphasized the importance of staying focused and giving it their all in every match remaining in the season.

    On the other hand, Celtic boss Brendan Rodgers has vowed that his league-leading team will not be taking their foot off the gas in the upcoming derby. Rodgers has made it clear that his players will not be softening up and will be giving their all to maintain their position at the top of the table.

    With so much at stake in this highly anticipated match, fans can expect an intense and thrilling battle between these two fierce rivals. Stay tuned for what is sure to be a game filled with drama, passion, and excitement.

    Tags:

    1. Rangers vs Celtic
    2. Philippe Clement
    3. Brendan Rodgers
    4. Football News
    5. Scottish Premiership
    6. Season Outlook
    7. League Leaders
    8. Competitive Rivalry
    9. Title Race
    10. Managerial Mindset

    #Rangers #Celtic #Philippe #Clement #insists #season #isnt #Brendan #Rodgers #vows #league #leaders #soften #Football #News

  • Hello, how can I help you today?
Gathering thoughts.. ...
Powered by AI
Chat Icon